Clinical Characteristics and Outcome of Children With Relapsed Medulloblastoma: A Retrospective Study at a Single Center in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Characteristics and Outcome of Children With Relapsed Medulloblastoma: A Retrospective Study at a Single Center in China

Published:2018-11 Issue:8 Volume:40 Page:598-604
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Du Shuxu,Yang Shuli,Zhao Xia,Xiao Jiang,Ren Siqi,Li Shuting,Zhang Jin,Wang Yuan,Gong Xiaojun,Li Miao,Sun Yanling,Wu Wanshui,Sun Liming

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference32 articles.

1. Posterior fossa tumors;Brandao;Neuroimaging Clin N Am,2017

2. Childhood medulloblastoma;Massimino;Crit Rev Oncol Hematol,2016

3. Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication;Weil;J Neurooncol,2017

4. Pediatric brain tumors: an update;Segal;Curr Probl Pediatr Adolesc Health Care,2016

5. Medulloblastoma: acommon pediatric tumor: prognostic factors and predictors of outcome;Kumar;Asian J Neurosurg,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach;Cancers;2022-10-19

2. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs;Acta Neuropathologica Communications;2022-02-24

3. Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children’s Cancer Group (CCCG);Neuro-Oncology Advances;2021-01-01

4. Etoposide-Bound Magnetic Nanoparticles Designed for Remote Targeting of Cancer Cells Disseminated Within Cerebrospinal Fluid Pathways;Frontiers in Neurology;2020-11-27

5.

LINC01094 Down-Regulates miR-330-3p and Enhances the Expression of MSI1 to Promote the Progression of Glioma

;Cancer Management and Research;2020-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3